OneSource Specialty Pharma, a rapidly growing Contract Development and Manufacturing Organisation (CDMO) in India, has announced that 360 ONE Asset, a leading asset management company, has acquired a stake in its business.
The investment comes at a pivotal moment in OneSource’s growth trajectory as it aims to solidify its leadership in biologics, drug-device combinations, complex injectables, and soft gelatine capsules.
360 ONE Asset Steps in for the Next Growth Phase
360 ONE Asset purchased its stake from an existing investor, aligning with OneSource’s vision to expand its global footprint.
Tarun Sharma, Fund Manager (Healthcare and Consumer) at 360 ONE Asset said, “We are delighted to back OneSource and its stellar team that has built a wide portfolio of capabilities. The company’s leadership in large molecules, complex injectables, and drug-device combinations positions it perfectly for the next phase of growth. We look forward to collaborating with OneSource as they continue their journey of innovation and global expansion”.
A Trusted Partner for Global Pharmaceutical Giants
Over the years, OneSource has built strong relationships with renowned pharmaceutical and biotech companies across the globe.
The company’s expertise in developing and manufacturing sophisticated products, such as GLP-1 medications and innovative biologics, sets it apart in the highly specialized CDMO market.
CEO Neeraj Sharma commented, “OneSource has established itself as a trusted development and manufacturing partner for top pharmaceutical companies worldwide. Our expertise in niche and complex dosage forms, along with our track record of superior compliance, allows us to provide an integrated, one-stop solution to our global clients. We are glad to welcome 360 ONE Asset as an investor who aligns with our mission to scale further”.
Cutting-Edge Facilities and Skilled Workforce
OneSource’s infrastructure and team provide a solid foundation for its ambitious expansion plans. The company operates five state-of-the-art manufacturing facilities.
Four of these are US FDA approved sites with flawless compliance records, underscoring the company’s commitment to excellence.
The Brand
360 ONE Asset, formerly known as IIFL Asset Management, manages $10 billion in assets. It also operates a $3 billion Venture Capital and Private Equity platform.
The firm has expertise in technology, financial services, healthcare, and consumer industries. It focuses on delivering unique investment opportunities in India.
As reported by privatebankerinternational.com, 360 ONE Asset has partnered with OneSource Specialty Pharma. This collaboration reinforces its commitment to supporting innovative businesses poised for global success.
